{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:20:49Z","timestamp":1778678449613,"version":"3.51.4"},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1996,6,15]]},"DOI":"10.1172\/jci118728","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T16:17:39Z","timestamp":1204301859000},"page":"2736-2744","source":"Crossref","is-referenced-by-count":89,"title":["Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein."],"prefix":"10.1172","volume":"97","author":[{"given":"G","family":"Murugesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P L","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/118728\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T17:01:39Z","timestamp":1691082099000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/118728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6,15]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1996,6,15]]}},"URL":"https:\/\/doi.org\/10.1172\/jci118728","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1996,6,15]]}}}